Complexity of valuation and risk management is increasing for both sell and buy side institutions, especially when cost of capital, counterparty credit risk and funding costs are included. To support best execution and risk reporting, firms need transparency into all aspects of a given price—including CVA, and preferably other valuation adjustments (xVA’s) as well. However, the reality is that